SEARCH

SEARCH BY CITATION

References

  • Abouleish E. (1976) Postpartum hypertension and convulsion after oxytocic drugs. Anesth. Analg. 55, 813815.
  • Alam A. M. and Starr M. S. (1993) Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience 53, 425431.
  • Albiston A. L., McDowall S. G., Matsacos D. et al. (2001) Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin- regulated aminopeptidase. J. Biol. Chem. 276, 48 62348 626.
  • Allen A. M., Zhuo J. and Mendelsohn F. A. O. (2000) Localization and function of angiotensin AT1 receptors. Am. J. Hypertens. 13, 31S38S.
  • Baf M. H., Subhash M. N., Lakshmana K. M. and Rao B. S. (1994a) Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem. Int. 24, 6772.
  • Baf M. H., Subhash M. N., Lakshmana K. M. and Rao B. S. (1994b) Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine. Neurochem. Res. 19, 11391143.
  • Biggs C. S., Pearce B. R., Fowler L. J. and Whitton P. S. (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study. J. Neurochem. 59, 17021708.
  • Binaschi A., Bregola G. and Simonato M. (2003) On the role of somatostatin in seizure control: clues from the hippocampus. Rev. Neurosci. 14, 285301.
  • Bradford H. F. (1995) Glutamate, GABA and epilepsy. Prog. Neurobiol. 47, 477511.
  • Braszko J. J., Wlasienko J., Kupryszewski G., Witczuk B. and Wisniewski K. (1988) Behavioral effects of angiotensin II and angiotensin II-(4–8)-pentapeptide in rats. Physiol. Behav. 44, 327332.
  • Cammalleri M., Cervia D., Langenegger D., Liu Y., Monte M. D., Hoyer D. and Bagnoli P. (2004) Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices. Eur. J. Neurosci. 20, 27112721.
  • Clinckers R., Smolders I., Meurs A., Ebinger G. and Michotte Y. (2004) Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors. J. Neurochem. 89, 834843.
  • Clinckers R., Gheuens S., Smolders I., Meurs A., Ebinger G. and Michotte Y. (2005a) In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin. Epilepsia 46, 828836.
  • Clinckers R., Smolders I., Meurs A., Ebinger G. and Michotte Y. (2005b) Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine. Neurosci. Lett. 390, 4853.
  • Colino A. and Halliwell J. V. (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328, 7377.
  • Croiset G. and De Wied D. (1997) Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system. Brain Res. 759, 1823.
  • Dailey J. W., Yan Q. S., Adams-Curtis L. E., Ryu J. R., Ko K. H., Mishra P. K. and Jobe P. C. (1996) Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci. 58, 259266.
  • Dailey J. W., Reith M. E., Yan Q. S., Li M. Y. and Jobe P. C. (1997a) Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose–response relationships. Neurosci. Lett. 227, 1316.
  • Dailey J. W., Reith M. E., Yan Q. S., Li M. Y. and Jobe P. C. (1997b) Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+. Eur. J. Pharmacol. 328, 153162.
  • Feniuk W., Jarvie E., Luo J. and Humphrey P. P. (2000) Selective somatostatin sst (2) receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology 39, 14431450.
  • Fernando R. N., Larm J., Albiston A. L. and Chai S. Y. (2005) Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system. J. Comp. Neurol. 487, 372390.
  • Fierens F. L. P., Vanderheyden P. M. L., Roggeman C., Vande Gucht P., De Backer J.-P. and Vauquelin G. (2001) Distinct binding properties of the AT1 receptor antagonist [3H]candesartan to intact cells and membrane preparations. Biochem. Pharmacol. 63, 12731279.
  • De Gasparo M., Catt K. J., Inagami T., Wright J. W. and Unger T. (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415472.
  • Graumlich J. F., McLaughlin R. G., Birkhahn D., Shah N., Burk A., Jobe P. C. and Dailey J. W. (1999) Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. Eur. J. Pharmacol. 369, 305311.
  • Herbst J. J., Ross S. A., Scott H. M., Bobin S. A., Morris N. J., Lienhard G. E. and Keller S. R. (1997) Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. Am. J. Physiol. 272, E600E606.
  • Hernandez E. J., Williams P. A. and Dudek F. E. (2002) Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 43, 13371345.
  • Konishi M., Nagashima K. and Kanosue K. (2002) Systemic salt loading decreases body temperature and increases heat-escape/cold-seeking behaviour via the central AT1 and V1 receptors in rats. J. Physiol. 545, 289296.
  • Le M. T., Vanderheyden P. M., Szaszak M., Hunyady L. and Vauquelin G. (2002) Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation. J. Biol. Chem. 277, 23 10723 110.
  • Lenkei Z., Palkovits M., Corvol P. and Llorens-Cortès C. (1997) Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front. Neuroendocrinol. 18, 383439.
  • Leventhal J. M. and Reid D. E. (1968) Oxytocin-induced water intoxication with grand mal convulsion. Am. J. Obstet. Gynecol. 102, 310311.
  • Lew R. A., Mustafa T. YeS., McDowall S. G., Chai S. Y. and Albiston A. L. (2003) Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J. Neurochem. 86, 344350.
  • Liu H., Mazarati A. M., Katsumori H., Sankar R. and Wasterlain C. G. (1999) Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc. Natl Acad. Sci. USA 96, 52865291.
  • Lu K. T. and Gean P. W. (1998) Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation. Neuroscience 86, 729737.
  • Mancillas J. R., Siggins G. R. and Bloom F. E. (1986) Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex. Proc. Natl Acad. Sci. USA 83, 75187521.
  • Matsumoto H., Rogi T., Yamashiro K., Kodama S., Tsuruoka N., Hattori A., Takio K., Mizutani S. and Tsujimoto M. (2000) Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur. J. Biochem. 267, 4652.
  • Matsumoto H., Nagasaka T., Hattori A., Rogi T., Tsuruoka N., Mizutani S. and Tsujimoto M. (2001) Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides. Eur. J. Biochem. 268, 32593266.
  • Mazarati A. M. and Telegdy G. (1992) Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures. Neuropharmacology 31, 793797.
  • Monno A., Rizzi M., Samanin R. and Vezzani A. (1993) Anti-somatostatin antibody enhances the rate of hippocampal kindling in rats. Brain Res. 602, 148152.
  • Murakami T., Okada M., Kawata Y., Zhu G., Kamata A. and Kaneko S. (2001) Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis. Br. J. Pharmacol. 134, 507520.
  • Mustafa T., Hyung Lee J., Yeen Chai S., Albiston A. L., McDowall S. G. and Mendelsohn F. A. O. (2001) Bioactive angiotensin peptides: focus on angiotensin IV. J. Renin Angiotensin Aldosterone Syst. 2, 205210.
  • Paxinos G. and Watson C. (1986) The Rat Brain in Stereotactic Coordinates, 2nd edn. American Press Inc, San Diego.
  • Pederson E. S., Harding J. W. and Wright J. W. (1998) Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. Regul. Pept. 74, 97103.
  • Racine R. J. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281294.
  • Roberts K. A., Krebs L. T., Kramar E. A., Shaffer M. J., Harding J. W. and Wright J. W. (1995) Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res. 682, 1321.
  • Salgado D. and Alkadhi K. A. (1995) Inhibition of epileptiform activity by serotonin in the rat CA1 neurons. Brain Res. 669, 176182.
  • Sarre S., Thorre K., Smolders I. and Michotte Y. (1997) Microbore liquid chromatography analysis of monoamine transmitters. Meth. Mol. Biol. 72, 185196.
  • Schmitz D., Gloveli T., Empson R. M. and Heinemann U. (1998) Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex. Mol. Neurobiol. 17, 5972.
  • Schweitzer P., Madamba S. G. and Siggins G. R. (1998) Somatostatin increases a voltage-insensitive K+ conductance in the rat CA1 hippocampal neurons. J. Neurophysiol. 79, 12301238.
  • Smolders I., Sarre S., Michotte Y. and Ebinger G. (1995) The analysis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography. J. Neurosci. Meth. 57, 4753.
  • Smolders I., Khan G. M., Lindekens H., Prikken S., Marvin C. A., Manil J., Ebinger G. and Michotte Y. (1997a) Effectiveness of vigabatrin against focally evoked pilocarpine-induced seizures and concomitant changes in extracellular hippocampal and cerebellar glutamate, gamma-aminobutyric acid and dopamine levels, a microdialysis-electrocorticography study in freely moving rats. J. Pharmacol. Exp. Ther. 283, 12391248.
  • Smolders I., Khan G. M., Manil J., Ebinger G. and Michotte Y. (1997b) NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis. Br. J. Pharmacol. 121, 11711179.
  • Smolders I., Van Belle K., Ebinger G. and Michotte Y. (1997c) Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. Eur. J. Pharmacol. 319, 2129.
  • Song K., Allen A. M., Paxinos G. and Mendelsohn F. A. (1992) Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J. Comp. Neurol. 316, 467484.
  • Starr M. S. (1996) The role of dopamine in epilepsy. Synapse 22, 159194.
  • Stragier B., Sarre S., Vanderheyden P., Vauquelin G., Fournié-Zaluski M.-C., Ebinger G. and Michotte Y. (2004) Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. J. Neurochem. 90, 12511257.
  • Suppes T., Kriegstein A. R. and Prince D. A. (1985) The influence of dopamine on epileptiform burst activity in hippocampal pyramidal neurons. Brain Res. 326, 273280.
  • Szczepanska-Sadowska E., Sobocinska J. and Sadowski B. (1982) Central dipsogenic effect of vasopressin. Am. J. Physiol. 242, R372R379.
  • Tallent M. K. and Siggins G. R. (1999) Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. J. Neurophysiol. 81, 16261635.
  • Tanaka T., Takeshita H., Kawahara R. and Hazama H. (1989) Chemical kindling with Met-enkephalin and transfer between chemical and electrical kindling. Epilepsy Res. 3, 214221.
  • Tchekalarova J. and Georgiev V. (2005) Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? Life Sci. 76, 955970.
  • Tchekalarova J., Kambourova T. and Georgiev V. (2001) Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A (1) receptors. Brain Res. Bull. 56, 8791.
  • Tchekalarova J., Sotiriou E. and Angelatou F. (2004) Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ. kindling model of epilepsy: effects of angiotensin IV. Brain Res. 1024, 159166.
  • Tchekalarova J., Sotiriou E., Georgiev V., Kostopoulos G. and Angelatou F. (2005) Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV. Brain Res. 1032, 94103.
  • Van Hemelrijck A., Sarre S., Smolders I. and Michotte Y. (2005) Determination of amino acids associated with cerebral ischaemia in rat brain microdialysates using narrowbore liquid chromatography and fluorescence detection. J. Neurosci. Meth. 144, 6371.
  • Vezzani A. and Hoyer D. (1999) Brain somatostatin: a candidate inhibitory role in seizures and epileptogenisis. Eur. J. Neurosci. 11, 37673776.
  • Wright J. W., Stubley L., Pederson E. S., Kramar E. A., Hanesworth J. M. and Harding J. W. (1999) Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J. Neurosci. 19, 39523961.
  • Yan Q. S., Mishra P. K., Burger R. L., Bettendorf A. F., Jobe P. C. and Dailey J. W. (1992) Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J. Pharmacol. Exp. Ther. 261, 652659.
  • Zhang J. Y., Zeise M. L. and Wang R. Y. (1994) Serotonin3 receptor agonists attenuate glutamate-induced firing in rat hippocampal CA1 pyramidal cells. Neuropharmacology 33, 483491.